Using tumor DNA found in urine, researchers believe they have found a method to diagnose and monitor bladder cancer that outperforms standard tests. A newly developed, highly sensitive urine test may ...
GAGome score had 90 percent sensitivity, 51 percent specificity for radiological recurrence, with AUC of 0.73 for nonmetastatic clear-cell renal cell carcinoma. (HealthDay News) — Urine ...
A urinary DNA methylation test demonstrated high sensitivity and specificity for detecting high-grade or invasive bladder cancer, outperforming both nuclear matrix protein 22 (NMP22) and urine ...
A simple and sensitive urine test has produced a color change in urine to signal growing tumors in mice. A simple and sensitive urine test developed by Imperial and MIT engineers has produced a colour ...
Please provide your email address to receive an email when new articles are posted on . MyProstateScore 2.0 showed high sensitivity for detecting aggressive prostate cancer without the need for a ...
The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...
The first fraction expelled during urination, called first-void urine (FVU), harbors high biomarker concentrations for diagnostic and disease monitoring applications. Recently, FVU has garnered ...
Urine panel had AUC of 0.96 and 0.92 with development and validation datasets, respectively, compared with 0.83 and 0.76 for urinary PCA3 RNA. HealthDay News — A urine-based biomarker panel has high ...
A simple urine test could detect pancreatic and prostate cancer with up to a 99% rate of accuracy, says a team of researchers from the Surface & Nano Materials Division of the Korea Institute of ...
A recent breakthrough study highlights how a simple at-home urine test could accurately detect prostate cancer. Researchers from Vanderbilt University and the University of Michigan suggest this ...
The MyProstateScore 2.0 urine test captures 17 biomarkers of clinically significant prostate cancer, independent of PSA. A positive result can rule in and a negative result can rule out the need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results